热门资讯> 正文
ADMA Biologics偿还3000万美元循环信贷安排
2024-08-14 21:11
- ADMA Biologics (NASDAQ:ADMA) said it has repaid $30 million from its original $72.5 million revolving credit facility with Ares Capital.
- After the partial paydown, ADMA has reduced its total gross debt to $105 million, comprised of its existing $62.5 million term loan and $42.5 million now outstanding under its revolving credit facility.
- The company funded the partial paydown with cash on hand.
More on ADMA Biologics
- ADMA stock rallies 21% on raised guidance, earnings beat
- ADMA Biologics GAAP EPS of $0.13 beats by $0.05, revenue of $107.19M beats by $20.78M
- Seeking Alpha’s Quant Rating on ADMA Biologics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
